Halyard Health (HYH) Tops Q1 EPS by 6c, Maintains FY EPS Guidance

Halyard Health (NYSE: HYH) reported Q1 EPS of $0.48, $0.06 better than the analyst estimate of $0.42. Revenue for the quarter came in at $396 million versus the consensus estimate of $392.2 million.

2017 Outlook and Key Planning Assumptions

The company maintains its full-year 2017 adjusted diluted earnings per share outlook of $1.70 to $2.00. Additionally, the key planning assumptions that it provided on its Year-End 2016 conference call, on February 27, remain unchanged.

For earnings history and earnings-related data on Halyard Health (HYH) click here.

You May Also Be Interested In

• Wolverine World Wide (WWW) Tops Q2 EPS by 2c; offers guidance
• Dillard's (DDS) Tops Q2 EPS by $1.93, Misses on Revenue
• Rockwell Medical (RMTI) Misses Q2 EPS by 1c